The Law Offices of Frank R. Cruz Announces Investigation of Harrow Health, Inc. (HROW) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Harrow Health, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On February 22, 2023, Bonitas Research published a report alleging, among other things, that Harrow had concealed a U.S. Department of Justice investigation into its sales practices and that it had engaged in suspect transactions with former subsidiaries. Moreover, Harrow did not disclose that it had received a warning letter from the U.S. Food and Drug Administration for making false and misleading marketing claims, but months later, the Company issued a nationwide recall.

On this news, Harrow’s stock price fell $0.54, or 3.2%, to close at $16.42 on February 22, 2023, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Harrow securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to [e-mail], or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.